| NCT06968845 | A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis | ACTIVE_NOT_RECRUITING | PHASE2 | 2025-05-02 | 2027-05-28 | 2027-05-28 |
| NCT05954988 | A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients | COMPLETED | PHASE1 | 2023-07-06 | 2024-09-25 | 2024-09-25 |
| NCT04159831 | A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions | COMPLETED | PHASE2 | 2020-09-26 | 2022-07-28 | 2022-03-31 |
| NCT04233814 | Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects | COMPLETED | PHASE1 | 2020-01-20 | 2021-12-23 | 2021-12-23 |